Sagent Pharmaceuticals, Inc. (SGNT) Misses Q1 EPS by 2c

Article Stock Quotes (1) Comments (0)

Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) reported Q1 EPS of ($0.30), $0.02 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $38.3 million versus the consensus estimate of $42.31 million.

For earnings history and earnings-related data on Sagent Pharmaceuticals, Inc. (SGNT) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
• La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
• Linktone Ltd. (LTON) Q1 Profit Slips to 10c/ADS

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?